In the closing of the recent trading day, IonQ, Inc. (IONQ) stood at $72.41, denoting a -6.63% move from the preceding trading day.

In the latest close session, Ouster, Inc. (OUST) was up +1.85% at $36.83. This move outpaced the S&P 500's daily gain of 0.4%. Elsewhere, the Dow saw a downswing of 0.04%, while the tech-heavy Nasdaq ...

A man who hasn’t been able to move or speak for years imagines picking up a cup and filling it with water. In response to the man’s thoughts, a robotic arm mounted on his wheelchair glides forward, ...

Alphabet (GOOGL) closed the most recent trading day at $251.03, moving +2.27% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.4%. Elsewhere, the Dow lost 0.04%, ...

Submission of application forms is underway for more than 1,200 vacancies. Check important details and direct link to apply.

Pursue groundbreaking research in artificial intelligence, machine learning, computer architecture and more with a Doctor of Philosophy (Ph.D.) in Computer Engineering from UMass Lowell. Join the ...

Documents often represent hours upon hours of precious work — and once they’re gone, ideas aren’t always easy to get back. So ...

We have left turns from Michigan and potholes from the pits of hell, but one local traffic oddity is an Old Pueblo original. What do you call a road that runs diagonally between an east-west street ...

In the most recent trading session, Sea Limited Sponsored ADR (SE) closed at $182.8, indicating a +1.1% shift from the previous trading day.

UC Berkeley professor Hany Farid says computer science students are struggling to find jobs. Farid said Berkeley grads used to have "the run of the place. That is not happening today." The advice ...

In the closing of the recent trading day, ASML (ASML) stood at $1, denoting a -3.93% move from the preceding trading day.

Humira (adalimumab) is used to treat several autoimmune conditions. The drug typically stays in your system for a few months after your final dose. This article explains how long Humira may remain in ...